Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boiled peanut powder is a processed form of peanuts that have been subjected to boiling and then ground into a fine powder. This product is being investigated primarily as an oral immunotherapy (OIT) for the treatment of peanut allergy. Boiling peanuts alters their protein structure, reducing allergenicity while preserving immunogenicity, which may allow for safer desensitization in allergic individuals compared to traditional roasted peanut products. Clinical trials have shown that using boiled peanut powder in OIT can induce tolerance or desensitization in children with confirmed peanut allergy, with potentially fewer adverse reactions than roasted forms[7][8][9]. The mechanism involves gradual exposure to reduced-allergenicity proteins, aiming to retrain the immune system and reduce IgE-mediated responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on boiled peanut powder.